These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23008223)

  • 1. Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Li HF; Gao X; Hong Y; Patwa HS; Chaudhry V; Rae-Grant AD; So YT; Alto P
    Neurology; 2012 Sep; 79(13):1411; author reply 1411. PubMed ID: 23008223
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Lerner V; Miodownik C
    Neurology; 2014 Feb; 82(7):643. PubMed ID: 24536064
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based guideline: Treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Lerner V; Miodownik C; Sheva B; Bhidayasiri R; Fahn S; Gronseth GS; Sullivan KL; Zesiewicz TA
    Neurology; 2013 Nov; 81(22):1967. PubMed ID: 24276337
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based guideline: Treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Neurology; 2013 Nov; 81(22):1968. PubMed ID: 24276338
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Subcommittee of the American Academy of Neurology.
    Brazzelli MG; Sandercock P; Wardlaw J
    Neurology; 2011 Jun; 76(23):2036-7; author reply 2038. PubMed ID: 21646634
    [No Abstract]   [Full Text] [Related]  

  • 7. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Khoo KF; Lepas B
    Neurology; 2014 Jan; 82(1):95. PubMed ID: 24379098
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Manchikanti L; Boswell MV; Giordano J; Kaplan E
    Neurology; 2007 Sep; 69(11):1190; author reply 1190-1. PubMed ID: 17846419
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Subcommittee of the American Academy of Neurology.
    Edlow JA
    Neurology; 2011 Jun; 76(23):2036; author reply 2038. PubMed ID: 21793246
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology.
    Pullman SL; Goodin DS; Marquinez AI; Tabbal S; Rubin M
    Neurology; 2000 Jul; 55(2):171-7. PubMed ID: 10908886
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
    Gomperts ED; Darr F
    Neurology; 2002 May; 58(9):1444. PubMed ID: 12011310
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Rison RA
    Neurology; 2010 Oct; 75(15):1397; author reply 1398-9. PubMed ID: 20960668
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Mauskop A
    Neurology; 2010 Oct; 75(15):1397; author reply 1398-9. PubMed ID: 20938035
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Sethi NK
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278969
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gonzalez-Duarte A
    Neurology; 2013 Oct; 81(16):1474-5. PubMed ID: 24278968
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Burneo JG; Escalaya AL
    Neurology; 2013 Oct; 81(16):1474. PubMed ID: 24127192
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Mahajan S; Engel WK
    Neurology; 2010 Oct; 75(15):1397-8; author reply 1398-9. PubMed ID: 20960612
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Bruce BB; Biousse V; Newman NJ
    Neurology; 2009 Jan; 72(4):382; author reply 382-3. PubMed ID: 19180681
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Friedman JH
    Neurology; 2009 Jan; 72(4):382; author reply 382-3. PubMed ID: 19171841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.